AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28839339 — intervention group
Group type: COMPARATOR
Intervention: Valbenazine (VBZ) 50 mg once-daily for 8 days (Cohort 2)
Number of subjects: 32
Study 28839339 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study 25355620 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits with calls
Number of subjects: 610
Study 25355620 — intervention group
Group type: EXPERIMENTAL
Intervention: Calls only
Number of subjects: 610
Study 23876867 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT) with verteporfin
Number of subjects: 93
Study 23876867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (3 monthly injections)
Number of subjects: 93
Study 21651392 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate IUD insertion
Number of subjects: 575
Study 21651392 — intervention group
Group type: COMPARATOR
Intervention: Delayed IUD insertion
Number of subjects: 575
Study 21651392 — intervention group
Group type: COMPARATOR
Intervention: Control group (Delayed insertion)
Number of subjects: 575
Study 19512871 — intervention group
Group type: EXPERIMENTAL
Intervention: AirTraq Laryngoscope
Number of subjects: 24
Study 19512871 — intervention group
Group type: COMPARATOR
Intervention: Macintosh Laryngoscope
Number of subjects: 24
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <60 years
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 60 to 75 years
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥75 years
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age (per 10-U change)
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher heart rate (per 10-U change)
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower systolic blood pressure (per 10-U change)
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure >80 mm Hg in elderly patients
Number of subjects: 761
Study 17350367 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min
Number of subjects: 761
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg/day (A)
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol 2mg/day (E)
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: E + Atorvastatin (E + A)
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: E + Norethisterone (E + P)
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: E + P + A
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: E + A
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: E
Number of subjects: 94
Study 15488870 — intervention group
Group type: EXPERIMENTAL
Intervention: A
Number of subjects: 94
Study 11673867 — intervention group
Group type: EXPERIMENTAL
Intervention: NADPH oxidase activation in wild-type mice
Number of subjects: 0
Study 11673867 — intervention group
Group type: COMPARATOR
Intervention: NADPH oxidase deficient mice
Number of subjects: 0
Study 11673867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis patients
Number of subjects: 0
Study 11673867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of o,o'-[(14)C]dityrosine into mice
Number of subjects: 0
Study 9476272 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado/soybean unsaponifiables
Number of subjects: 164
Study 9476272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 7884017 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular zuclopenthixol acetate (50 to 150 mg every 3 days)
Number of subjects: 40
Study 7884017 — intervention group
Group type: COMPARATOR
Intervention: Liquid oral haloperidol (10 to 30 mg daily, three times a day)
Number of subjects: 40
Study 3279235 — intervention group
Group type: EXPERIMENTAL
Intervention: Unna's boots (UB)
Number of subjects: 69
Study 3279235 — intervention group
Group type: COMPARATOR
Intervention: hydroactive dressing (HD)
Number of subjects: 69
Study 31843270 — intervention group
Group type: EXPERIMENTAL
Intervention: Strep A vaccine (StreptAnova™), administered intramuscularly at 0, 30, and 180 days
Number of subjects: 36
Study 31843270 — intervention group
Group type: COMPARATOR
Intervention: Alum-based comparator (control group)
Number of subjects: 36
Study 31843270 — intervention group
Group type: EXPERIMENTAL
Intervention: Strep A vaccine (StreptAnova™)
Number of subjects: 36
Study 25886746 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 32
Study 25886746 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 32
Study 25886746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23930573 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate monomer containing resin (Panavia 21 TC; N = 16)
Number of subjects: 30
Study 23930573 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive bonding system with a phosphoric acid acrylate primer (Multilink‐Automix with Metal/Zirconia primer; N = 14)
Number of subjects: 30
Study 21279976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pentoxifylline
Number of subjects: 30
Study 21279976 — intervention group
Group type: COMPARATOR
Intervention: Pulse steroid and cyclophosphamide therapy
Number of subjects: 30
Study 21279976 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 subjects)
Number of subjects: 30
Study 19959695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-managed, lay-led tobacco cessation intervention with nicotine replacement and behavioral counseling
Number of subjects: 302
Study 19959695 — intervention group
Group type: COMPARATOR
Intervention: Personalized letter from clinic physician advising to quit smoking
Number of subjects: 302
Study 17680469 — intervention group
Group type: EXPERIMENTAL
Intervention: LACE training (four-week adaptive auditory training and aural rehabilitation program)
Number of subjects: 0
Study 17680469 — intervention group
Group type: EXPERIMENTAL
Intervention: LACE training
Number of subjects: 0
Study 15792759 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (Hemaseel APR)
Number of subjects: 82
Study 15792759 — intervention group
Group type: COMPARATOR
Intervention: Control (drain placement)
Number of subjects: 82
Study 12137179 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowling harness
Number of subjects: 33
Study 12137179 — intervention group
Group type: COMPARATOR
Intervention: Non-harness group
Number of subjects: 33
Study 10436756 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue 0.3 ml
Number of subjects: 12
Study 10436756 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue 0.6 ml
Number of subjects: 12
Study 10436756 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue 1.2 ml
Number of subjects: 12
Study 10436756 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue 2.4 ml
Number of subjects: 12
Study 10436756 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (all doses)
Number of subjects: 12
Study 7763040 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective lymph node dissection (ELND)
Number of subjects: 0
Study 7763040 — intervention group
Group type: COMPARATOR
Intervention: Delayed dissection
Number of subjects: 0
Study 7763040 — intervention group
Group type: COMPARATOR
Intervention: Patients who decline ELND
Number of subjects: 0
Study 2265300 — intervention group
Group type: EXPERIMENTAL
Intervention: ITC hearing aids
Number of subjects: 244
Study 2265300 — intervention group
Group type: EXPERIMENTAL
Intervention: ITE hearing aids
Number of subjects: 244
Study 2265300 — intervention group
Group type: COMPARATOR
Intervention: BTE hearing aids
Number of subjects: 244
Study 7372822 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic treatment
Number of subjects: 60
Study 7372822 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback treatment
Number of subjects: 60
Study 7372822 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophotropic treatment
Number of subjects: 60
Study 7372822 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 31216846 — intervention group
Group type: EXPERIMENTAL
Intervention: PIEB 10 ml every 60 min (Group 10q60)
Number of subjects: 150
Study 31216846 — intervention group
Group type: EXPERIMENTAL
Intervention: PIEB 5 ml every 30 min (Group 5q30)
Number of subjects: 150
Study 31216846 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion (CEI) 10 ml/h
Number of subjects: 150
Study 28694268 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlamydia testing
Number of subjects: 0
Study 28694268 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlamydia incidence
Number of subjects: 0
Study 26088268 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab 1 g
Number of subjects: 47
Study 26088268 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab 2 g
Number of subjects: 47
Study 26088268 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab 4 g
Number of subjects: 47
Study 26088268 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab 5 g plus 2.5 g
Number of subjects: 47
Study 26088268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 23104146 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron 8 mg
Number of subjects: 118
Study 23104146 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 118
Study 21606305 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea therapy (part of the BABY HUG trial)
Number of subjects: 203
Study 19114574 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 165
Study 19114574 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study 17020438 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150-600 mg)
Number of subjects: 0
Study 17020438 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study 14595564 — intervention group
Group type: EXPERIMENTAL
Intervention: Posture change from supine to seated
Number of subjects: 30
Study 14595564 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 70% maximum oxygen uptake
Number of subjects: 30
Study 14595564 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 30
Study 11468198 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 131
Study 11468198 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study 11479983 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 0.3% triclosan and 2.0% PVM/MA copolymer in a 0.243% sodium fluoride/silica base
Number of subjects: 153
Study 11479983 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice (0.243% sodium fluoride silica base)
Number of subjects: 153
Study 7685442 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 12
Study 7685442 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 12
Study 7685442 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan > 10 mg
Number of subjects: 12
Study 7685442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2444780 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (mean dose, 70 mg/day)
Number of subjects: 15
Study 2444780 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin patches (mean dose, 16 cm/day)
Number of subjects: 15
Study 2444780 — intervention group
Group type: COMPARATOR
Intervention: Control period (no other antianginal treatment)
Number of subjects: 15
Study 29764853 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 monotherapy (300 mg, every day, days 1-14/21)
Number of subjects: 169
Study 29764853 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 in combination with carboplatin (300 mg, every day, days 1-14/21)
Number of subjects: 169
Study 29764853 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 in combination with nab-paclitaxel (200 mg, every day, days 1-14/21)
Number of subjects: 169
Study 29764853 — intervention group
Group type: COMPARATOR
Intervention: CC-486 (various doses)
Number of subjects: 169
Study 26915749 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (n=108)
Number of subjects: 217
Study 26915749 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (n=109)
Number of subjects: 217
Study 25129664 — intervention group
Group type: EXPERIMENTAL
Intervention: everolimus-eluting stent
Number of subjects: 140
Study 23041961 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training before high-intensity resistance training (BLRT)
Number of subjects: 30
Study 23041961 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training after high-intensity resistance training (ALRT)
Number of subjects: 30
Study 23041961 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training before high-intensity resistance training (BLRT) and Low-intensity resistance training after high-intensity resistance training (ALRT)
Number of subjects: 30
Study 23041961 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 30
Study 21592681 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (100mg daily)
Number of subjects: 129
Study 21592681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 19591337 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% cetylpyridinium chloride (CPC) mouthrinse
Number of subjects: 43
Study 19591337 — intervention group
Group type: COMPARATOR
Intervention: Control mouthrinse without 0.05% CPC
Number of subjects: 43
Study 16822077 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tears applied in patients with dry-eye syndrome or contact lenses
Number of subjects: 0
Study 16822077 — intervention group
Group type: COMPARATOR
Intervention: Healthy eyes
Number of subjects: 0
Study 16822077 — intervention group
Group type: COMPARATOR
Intervention: Dry-eye syndrome
Number of subjects: 0
Study 16822077 — intervention group
Group type: COMPARATOR
Intervention: Contact lenses
Number of subjects: 0
Study 12757574 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced balance training for 6 weeks consisting of repetitive tasks of increasing difficulty specific to functional balance.
Number of subjects: 199
Study 12757574 — intervention group
Group type: COMPARATOR
Intervention: Control group received physiotherapy conforming to existing practice in elderly patients with mobility problems.
Number of subjects: 199
Study 10906618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 0
Study 9262265 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus injection of FSH (450 IU i.m.)
Number of subjects: 12
Study 9262265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8365747 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 x 10(6) units of streptokinase (SK) in 200 ml of normal saline
Number of subjects: 100
Study 8365747 — intervention group
Group type: COMPARATOR
Intervention: 200 ml of normal saline alone (control)
Number of subjects: 100
Study 3060889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 1.5 micrograms/kg IV
Number of subjects: 22
Study 3060889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 2.0 micrograms/kg IV
Number of subjects: 22
Study 3060889 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study 3060889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 2.0 micrograms/kg IV (repeated tests)
Number of subjects: 22
Study 30968559 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 0
Study 30968559 — intervention group
Group type: COMPARATOR
Intervention: Xience everolimus eluting stent (EES)
Number of subjects: 0
Study 28914732 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 360
Study 28914732 — intervention group
Group type: EXPERIMENTAL
Intervention: Family/friend social support for healthy eating
Number of subjects: 360
Study 28914732 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 360
Study 28914732 — intervention group
Group type: EXPERIMENTAL
Intervention: Social problems
Number of subjects: 360
Study 28914732 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical comfort and family relations WRQOL
Number of subjects: 360
Study 27595715 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session root canal treatment (GSS)
Number of subjects: 26
Study 27595715 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session root canal treatment with calcium hydroxide intracanal medication (GTS)
Number of subjects: 26
Study 25531935 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 681
Study 25531935 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 681
Study 23013624 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori-positive group (n=95)
Number of subjects: 174
Study 23013624 — intervention group
Group type: COMPARATOR
Intervention: H. pylori-negative group (n=79)
Number of subjects: 174
Study 20628004 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (6 cups daily for 3 to 6 weeks)
Number of subjects: 17
Study 20628004 — intervention group
Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 17
Study 20628004 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG incubation with LNCaP prostate cancer cells
Number of subjects: 17
Study 18173402 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocrystalline hydroxyapatite (NHA)
Number of subjects: 22
Study 18173402 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural bone mineral in combination with a collagen membrane (NBM+CM)
Number of subjects: 22
Study 16595780 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin (30 mg/day)
Number of subjects: 1190
Study 16595780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1190
Study 16595780 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1190
Study 12560950 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 29
Study 12560950 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 29
Study 10546924 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil
Number of subjects: 9
Study 10546924 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 9
Study 10546924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8735992 — intervention group
Group type: COMPARATOR
Intervention: Blocked practice
Number of subjects: 64
Study 8735992 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 64
Study 1659474 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 25
Study 1659474 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT 99Tcm (V) DMSA
Number of subjects: 25
Study 1659474 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined imaging with CT
Number of subjects: 25
Study 1659474 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 25
Study 7171415 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 10 mg i.v. (acute administration)
Number of subjects: 26
Study 31894444 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention including health education, relationship-building skills, and Couples HIV Testing and Counseling
Number of subjects: 96
Study 31894444 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 96
Study 31894444 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 96
Study 31253425 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fitting guide
Number of subjects: 183
Study 31253425 — intervention group
Group type: COMPARATOR
Intervention: Previous fitting guide
Number of subjects: 183
Study 28146065 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyGlycopleX® (PGX)
Number of subjects: 0
Study 28146065 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium (PSY)
Number of subjects: 0
Study 28146065 — intervention group
Group type: COMPARATOR
Intervention: Control (rice flour)
Number of subjects: 0
Study 24021606 — intervention group
Group type: EXPERIMENTAL
Intervention: One specific physical treatment device using a biorhythmically defined stimulus for vasomotion
Number of subjects: 0
Study 24021606 — intervention group
Group type: COMPARATOR
Intervention: Two other physical treatment devices
Number of subjects: 0
Study 24021606 — intervention group
Group type: COMPARATOR
Intervention: Three other physical treatment devices
Number of subjects: 0
Study 21106921 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole pecans
Number of subjects: 16
Study 21106921 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended pecans
Number of subjects: 16
Study 21106921 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole and blended pecans pooled
Number of subjects: 16
Study 20070133 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Psychotherapy (CBT)
Number of subjects: 0
Study 20070133 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped Collaborative Care (CC)
Number of subjects: 0
Study 20070133 — intervention group
Group type: COMPARATOR
Intervention: CC (Control)
Number of subjects: 0
Study 17470831 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab plus prednisone
Number of subjects: 51
Study 17470831 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 51
Study 15166683 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 mg/kg/dose, twice a day)
Number of subjects: 34
Study 11669586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound scans performed by the surgeon in Group 1 (n=213)
Number of subjects: 302
Study 11669586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound scans performed by the surgeon in Group 2 (n=231)
Number of subjects: 302